Aon (AON) delivered mixed results for Q4 2024 as adjusted EPS beat, but revenue missed Wall Street expectations. The ...

General Dynamics presents a compelling value opportunity amid recent share price weakness, despite strong operational ...

Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...

Oil may be exempt from new tariffs despite President Trump's threats due to the complex nature of the U.S. energy industry.

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Wizz Air stock fell due to Q3 results, revised 2025 outlook, and fleet plan, highlighting high-risk but potentially ...

Elemental Altus Royalties shows strong growth but volatile stock performance. Learn why ELE:CA stock is rated "Hold" while ...

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

The copper market enters 2025 with even more uncertainty than usual. How is our copper exposure looking? Click here to find ...

Baker Hughes posted solid growth, driven by IET and US LNG demand. Find out why BKR stock’s fair valuation and capped oil ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful ...